Dow Up 0.84% Nasdaq Up 1.27%

Celgene Corporation (CELG)

-NasdaqGS
108.47 Up 1.53(1.43%) 9:47AM EDT - Nasdaq Real Time Price
Prev Close:106.94
Open:108.74
Bid:109.00 x 22800
Ask:109.05 x 300
1y Target Est:111.55
Beta:1.5
Next Earnings Date:N/A
Day's Range:108.39 - 109.24
52wk Range:66.85 - 109.24
Volume:675,769
Avg Vol (3m):4,801,680
Market Cap:86.64B
P/E (ttm):56.82
EPS (ttm):1.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
CELGUp 1.43%86.64B
JNJUp 0.68%303.94B

Key Statistics

Forward P/E (1 yr):22.29
P/S (ttm):11.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback